Mani Foroohar

Stock Analyst at Leerink Partners

(3.25)
# 1,077
Out of 5,044 analysts
171
Total ratings
52.13%
Success rate
1.05%
Average return

Stocks Rated by Mani Foroohar

Lexeo Therapeutics
Oct 7, 2025
Maintains: Outperform
Price Target: $9$20
Current: $10.08
Upside: +98.41%
Rocket Pharmaceuticals
Oct 3, 2025
Maintains: Market Perform
Price Target: $9$7
Current: $3.97
Upside: +76.32%
Moderna
Aug 22, 2025
Maintains: Underperform
Price Target: $18$15
Current: $25.35
Upside: -40.83%
Sarepta Therapeutics
Jul 21, 2025
Downgrades: Market Perform
Price Target: $45$10
Current: $24.22
Upside: -58.71%
Recursion Pharmaceuticals
Feb 28, 2025
Maintains: Market Perform
Price Target: $7$6
Current: $5.91
Upside: +1.52%
4D Molecular Therapeutics
Jan 13, 2025
Maintains: Outperform
Price Target: $31$27
Current: $11.97
Upside: +125.56%
Neurogene
Nov 12, 2024
Maintains: Outperform
Price Target: $45$72
Current: $30.96
Upside: +132.56%
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: $17
Current: $3.91
Upside: +334.78%
Mirum Pharmaceuticals
Oct 17, 2024
Maintains: Outperform
Price Target: $47$49
Current: $70.51
Upside: -30.51%
BridgeBio Pharma
Oct 17, 2024
Maintains: Outperform
Price Target: $47$46
Current: $64.50
Upside: -28.68%
Maintains: Outperform
Price Target: $20$22
Current: $7.59
Upside: +189.86%
Upgrades: Outperform
Price Target: $53$62
Current: $73.57
Upside: -15.73%
Initiates: Outperform
Price Target: $13
Current: $16.17
Upside: -19.60%
Initiates: Outperform
Price Target: $29
Current: $21.77
Upside: +33.21%
Downgrades: Market Perform
Price Target: $12$4
Current: $5.37
Upside: -25.51%
Upgrades: Outperform
Price Target: n/a
Current: $13.16
Upside: -
Initiates: Outperform
Price Target: $31
Current: $7.81
Upside: +296.93%
Initiates: Outperform
Price Target: $7
Current: $1.56
Upside: +348.72%
Downgrades: Market Perform
Price Target: $40
Current: $39.55
Upside: +1.14%
Maintains: Outperform
Price Target: $86$84
Current: $13.96
Upside: +501.72%
Maintains: Market Perform
Price Target: $6$7
Current: $3.17
Upside: +120.82%
Maintains: Outperform
Price Target: $81$77
Current: $26.43
Upside: +191.34%
Maintains: Market Perform
Price Target: $144$143
Current: $475.91
Upside: -69.95%
Maintains: Market Perform
Price Target: $5$6
Current: $5.28
Upside: +13.64%
Maintains: Outperform
Price Target: $75$76
Current: $64.17
Upside: +18.44%
Maintains: Outperform
Price Target: $30$34
Current: $2.47
Upside: +1,276.52%
Maintains: Market Perform
Price Target: $50$20
Current: $4.26
Upside: +369.48%